Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
World's first Dengue vaccine out
Dengue is one of the most devastating mosquito borne diseases in the world.
FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
PARIS, Feb.
Teva begins process of building new brand
JERUSALEM — Teva Pharmaceutical Industries announced Wednesday that it was starting the process of building a global brand via a corporate identity program that will span its enterprise.
Bayer Receives EU Approval of Kovaltry for Treatment of Hemophilia A
Leverkusen, February 22, 2016 – Bayer has received approval from the European Commission of Kovaltry® for the treatment of hemophilia A in patients of all age groups.
Japanese company produces fastest vaccines using tobacco leaves
Tokyo, Feb 23 (EFE).
OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
TAIPEI, Taiwan, Feb.
Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association
HERTFORDSHIRE, England and PITTSBURGH, Feb.
Lannett Receives FDA Approval For Temozolomide Capsules
Lannett Company, Inc.
Cipla EU completes $550m acquisition of US firms InvaGen and Exelan
Indian-based Cipla's UK division has completed the acquisition of InvaGen Pharmaceuticals and Exelan Pharmaceuticals in previously announced deals worth $550m.
US researchers develop 'mini-brains' to study neurological disorders
Researchers at the Johns Hopkins Bloomberg School of Public Health, US, have developed 'mini-brains' to study neurological diseases.
CDC, Brazil start big study to test Zika link to birth defects
U.
Zurampic (lesinurad) approved in the European Union for patients with gout
AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for ZurampicTM (lesinurad) 200mg in combination with a xanthine oxidase inhibitor (...
612
613
614
615
616
617
618
619
620
